News

Researchers found that all of the brains of dementia patients showed quinolinic acid neurotoxicity. This acid kills nerve cells in the brain, leading to brain dysfunction and ultimately

The Canadian late phase trial commenced on December 2, 2004 and includes a total of 453 patients with stable moderate to severe plaque psoriasis. The trial is currently

The clinical development of the drug, which has been granted orphan drug designation in the US and Europe, is about to enter a phase III clinical study in

Researchers looking for such a link have focused on acetaldehyde, a suspected carcinogen formed as the body metabolizes alcohol. The researchers claim that polyamines – natural compounds essential

AA4500 is being developed by Auxilium, whilst Cobra will continue to provide manufacturing services and supply the drug for phase II/III clinical trials. “We have been impressed with

The drugs in question are daclizumab in multiple sclerosis and indications other than transplant and respiratory diseases, M200 (volociximab), and HuZAF (fontolizumab) in all indications. Protein Design Labs

More than 120 sites across the US have been enlisted and most are now screening and enrolling patients into the study. Myriad anticipates completing enrollment for the 12-month

The grant is a fast-track phase I/II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Currently, the

“The increasing number of less invasive procedures, particularly endoscopic and laprascopic procedures requires more demanding suture knot tying skills,” noted Wade Fallin, president and CEO of MedicineLodge. “These